Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons

Molecular and Cellular Neuroscience

Volumn 24, Issue 3, 2003, Pages 803-817

  Maier, Marcel ^a   Castagner, François ^a   Berger, Philipp ^a   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; PERIPHERAL MYELIN PROTEIN 22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSECTION; DNA FLANKING REGION; GENE CONTROL; GENE LOCATION; MOLECULAR DYNAMICS; MOUSE; MYELINATED NERVE; MYELINATION; NERVE INJURY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REMYELINIZATION; SCHWANN CELL; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0345167822     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00246-X     Document Type: Article

References (82)

1. Adlkofer K., Frei R., Neuberg D.H., Zielasek J., Toyka K.V., Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J. Neurosci. 17:1997;4662-4671.
2. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11:1995;274-280.
3. Aguayo A.J., Charron L., Bray G.M. Potential of Schwann cells from unmyelinated nerves to produce myelin a quantitative ultrastructural and radiographic study . J. Neurocytol. 5:1976;565-573.
4. Aguayo A.J., Epps J., Charron L., Bray G.M. Multipotentiality of Schwann cells in cross-anastomosed and grafted myelinated and unmyelinated nerves quantitative microscopy and radioautography . Brain Res. 104:1976;1-20.
5. Baechner D., Liehr T., Hameister H., Altenberger H., Grehl H., Suter U., Rautenstrauss B. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development. J. Neurosci. Res. 42:1995;733-741.
6. Benbrook D.M., Jones N.C. Different binding specificities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res. 22:1994;1463-1469.
7. Berger P., Young P., Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics. 4:2002;1-15.
8. Bermingham J.R. Jr., Scherer S.S., O'Connell S., Arroyo E., Kalla K.A., Powell F.L., Rosenfeld M.G. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 10:1996;1751-1762.
9. Boerkoel C.F., Takashima H., Bacino C.A., Daentl D., Lupski J.R. EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics. 3:2001;153-157.
10. Brancolini C., Edomi P., Marzinotto S., Schneider C. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases . Mol. Biol. Cell. 11:2000;2901-2914.
11. Brancolini C., Marzinotto S., Edomi P., Agostoni E., Fiorentini C., Muller H.W., Schneider C. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol. Biol. Cell. 10:1999;2441-2459.
12. Britsch S., Goerich D.E., Riethmacher D., Peirano R.I., Rossner M., Nave K.A., Birchmeier C., Wegner M. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15:2001;66-78.
13. Chalepakis G., Gruss P. Identification of DNA recognition sequences for the Pax3 paired domain. Gene. 162:1995;267-270.
14. Chance P.F., Alderson M.K., Leppig K.A., Lensch M.W., Matsunami N., Smith B., Swanson P.D., Odelberg S.J., Disteche C.M., Bird T.D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 72:1993;143-151.
15. Chies R., Nobbio L., Edomi P., Schenone A., Schneider C., Brancolini C. Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22. J. Cell Sci. 116:2003;987-999.
16. Dickson K.M., Bergeron J.J., Shames I., Colby J., Nguyen D.T., Chevet E., Thomas D.Y., Snipes G.J. Association of calnexin with mutant peripheral myelin protein-22 ex vivo a basis for "gain-of-function" ER diseases . Proc. Natl. Acad. Sci. USA. 99:2002;9852-9857.
17. Dubchak I., Brudno M., Loots G.G., Pachter L., Mayor C., Rubin E.M., Frazer K.A. Active conservation of noncoding sequences revealed by three-way species comparisons. Genome Res. 10:2000;1304-1306.
18. Fabbretti E., Edomi P., Brancolini C., Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22 its relation to the demyelinating peripheral neuropathy CMT1A . Genes Dev. 9:1995;1846-1856.
19. Forghani R., Garofalo L., Foran D.R., Farhadi H.F., Lepage P., Hudson T.J., Tretjakoff I., Valera P., Peterson A. A distal upstream enhancer from the myelin basic protein gene regulates expression in myelin-forming schwann cells. J. Neurosci. 21:2001;3780-3787.
20. Ghislain J., Desmarquet-Trin-Dinh C., Jaegle M., Meijer D., Charnay P., Frain M. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development. 129:2002;155-166.
21. Gravel M., Di Polo A., Valera P.B., Braun P.E. Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J. Neurosci. Res. 53:1998;393-404.
22. Hai M., Bidichandani S.I., Patel P.I. Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene. J. Neurosci. Res. 65:2001;508-519.
23. Hardison R., Slightom J.L., Gumucio D.L., Goodman M., Stojanovic N., Miller W. Locus control regions of mammalian beta-globin gene clusters combining phylogenetic analyses and experimental results to gain functional insights . Gene. 205:1997;73-94.
24. He X., Gerrero R., Simmons D.M., Park R.E., Lin C.J., Swanson L.W., Rosenfeld M.G. Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule P0. Mol. Cell Biol. 11:1991;1739-1744.
25. He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W., Rosenfeld M.G. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature. 340:1989;35-41.
26. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., Kolchanov N.A. Databases on transcriptional regulation TRANSFAC, TRRD and COMPEL . Nucleic Acids Res. 26:1998;362-367.
27. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pellissier J.F., Fontes M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5:1996;563-569.
28. Ikenaka K., Kagawa T. Transgenic systems in studying myelin gene expression. Dev. Neurosci. 17:1995;127-136.
29. Jaegle M., Ghazvini M., Mandemakers W., Piirsoo M., Driegen S., Levavasseur F., Raghoenath S., Grosveld F., Meijer D. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev. 17:2003;1380-1391.
30. Jaegle M., Mandemakers W., Broos L., Zwart R., Karis A., Visser P., Grosveld F., Meijer D. The POU factor Oct-6 and Schwann cell differentiation. Science. 273:1996;507-510.
31. Jaegle M., Meijer D. Role of Oct-6 in Schwann cell differentiation. Microsc. Res. Tech. 41:1998;372-378.
32. Kothary R., Clapoff S., Brown A., Campbell R., Peterson A., Rossant J. A transgene containing lacZ inserted into the dystonia locus is expressed in neural tube. Nature. 335:1988;435-437.
33. Kothary R., Clapoff S., Darling S., Perry M.D., Moran L.A., Rossant J. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development. 105:1989;707-714.
34. Li P., He X., Gerrero M.R., Mok M., Aggarwal A., Rosenfeld M.G. Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7:1993;2483-2496.
35. Lobsiger C.S., Taylor V., Suter U. The early life of a Schwann cell. Biol. Chem. 383:2002;245-253.
36. Lupski J.R., de Oca Luna R.M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B.J., Saucedo-Cardenas O., Barker D.F., Killian J.M., Garcia C.A., Chakravarti A., Patel P.I. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 66:1991;219-232.
37. Magyar J.P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K.V., Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16:1996;5351-5360.
38. Maier M., Berger P., Nave K.A., Suter U. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol. Cell Neurosci. 20:2002;93-109.
39. Maier M., Berger P., Suter U. Understanding Schwann cell-neurone interactions the key to Charcot-Marie-Tooth disease . J. Anat. 200:2002;357-366.
40. Mandemakers W., Zwart R., Jaegle M., Walbeehm E., Visser P., Grosveld F., Meijer D. A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration. EMBO J. 19:2000;2992-3003.
41. Manfioletti G., Ruaro M.E., Del Sal G., Philipson L., Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein. Mol. Cell Biol. 10:1990;2924-2930.
42. Mayor C., Brudno M., Schwartz J.R., Poliakov A., Rubin E.M., Frazer K.A., Pachter L.S., Dubchak I. VISTA visualizing global DNA sequence alignments of arbitrary length . Bioinformatics. 16:2000;1046-1047.
43. Mirsky R., Jessen K.R. The neurobiology of Schwann cells. Brain Pathol. 9:1999;293-311.
44. Mirsky R., Jessen K.R., Brennan A., Parkinson D., Dong Z., Meier C., Parmantier E., Lawson D. Schwann cells as regulators of nerve development. J. Physiol. (Paris). 96:2002;17-24.
45. Nagarajan R., Svaren J., Le N., Araki T., Watson M., Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron. 30:2001;355-368.
46. Nelson C.C., Hendy S.C., Shukin R.J., Cheng H., Bruchovsky N., Koop B.F., Rennie P.S. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors evidence for differential steroid receptor response elements . Mol. Endocrinol. 13:1999;2090-2107.
47. Neuberg D.H., Sancho S., Suter U. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32. J. Neurosci. Res. 58:1999;612-623.
48. Nickols J.C., Valentine W., Kanwal S., Carter B.D. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat. Neurosci. 6:2003;161-167.
49. Niemann S., Sereda M.W., Suter U., Griffiths I.R., Nave K.A. Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J. Neurosci. 20:2000;4120-4128.
50. Notterpek L., Roux K.J., Amici S.A., Yazdanpour A., Rahner C., Fletcher B.S. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc. Natl. Acad. Sci. USA. 98:2001;14404-14409.
51. Paca-Uccaralertkun S., Zhao L.J., Adya N., Cross J.V., Cullen B.R., Boros I.M., Giam C.Z. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol. Cell Biol. 14:1994;456-462.
52. Palmer C.N., Hsu M.H., Griffin H.J., Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:1995;16114-16121.
53. Paratore C., Goerich D.E., Suter U., Wegner M., Sommer L. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development. 128:2001;3949-3961.
54. Paratore C., Hagedorn L., Floris J., Hari L., Kleber M., Suter U., Sommer L. Cell-intrinsic and cell-extrinsic cues regulating lineage decisions in multipotent neural crest-derived progenitor cells. Int. J. Dev. Biol. 46:2002;193-200.
55. Parmantier E., Braun C., Thomas J.L., Peyron F., Martinez S., Zalc B. PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns. J. Comp. Neurol. 378:1997;159-172.
56. Parmantier E., Cabon F., Braun C., D'Urso D., Muller H.W., Zalc B. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur. J. Neurosci. 7:1995;1080-1088.
57. Patel P.I., Roa B.B., Welcher A.A., Schoener-Scott R., Trask B.J., Pentao L., Snipes G.J., Garcia C.A., Francke U., Shooter E.M., et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1:1992;159-165.
58. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector new fast and versatile tools for detection of consensus matches in nucleotide sequence data . Nucleic Acids Res. 23:1995;4878-4884.
59. Robertson A.M., Perea J., McGuigan A., King R.H., Muddle J.R., Gabreels-Festen A.A., Thomas P.K., Huxley C. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J. Anat. 200:2002;377-390.
60. Rossant J., Zirngibl R., Cado D., Shago M., Giguere V. Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev. 5:1991;1333-1344.
61. Saberan-Djoneidi D., Sanguedolce V., Assouline Z., Levy N., Passage E., Fontes M. Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene. 248:2000;223-231.
62. Scherer S.S. The biology and pathobiology of Schwann cells. Curr. Opin. Neurol. 10:1997;386-397.
63. Schneider C., King R.M., Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 54:1988;787-793.
64. Sereda M., Griffiths I., Puhlhofer A., Stewart H., Rossner M.J., Zimmermann F., Magyar J.P., Schneider A., Hund E., Meinck H.-M., Suter U., Nave K.A. A rat transgenic model for Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
65. Sim F., Zhao C., Li W., Lakatos A., Franklin R. Expression of the POU-domain transcription factors SCIP/Oct-6 and Brn-2 is associated with Schwann cell but not oligodendrocyte remyelination of the CNS. Mol. Cell Neurosci. 20:2002;669.
66. Smit A.F. The origin of interspersed repeats in the human genome. Curr. Opin. Genet. Dev. 6:1996;743-748.
67. Snipes G.J., Suter U., Welcher A.A., Shooter E.M. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J. Cell Biol. 117:1992;225-238.
68. Spreyer P., Kuhn G., Hanemann C.O., Gillen C., Schaal H., Kuhn R., Lemke G., Muller H.W. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J. 10:1991;3661-3668.
69. Suter U., Snipes G.J., Schoener-Scott R., Welcher A.A., Pareek S., Lupski J.R., Murphy R.A., Shooter E.M., Patel P.I. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem. 269:1994;25795-25808.
70. Swirnoff A.H., Milbrandt J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell Biol. 15:1995;2275-2287.
71. Timmerman V., De Jonghe P., Ceuterick C., De Vriendt E., Lofgren A., Nelis E., Warner L.E., Lupski J.R., Martin J.J., Van Broeckhoven C. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology. 52:1999;1827-1832.
72. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature. 371:1994;796-799.
73. van de Wetering R.A., Gabreels-Festen A.A., Kremer H., Kalscheuer V.M., Gabreels F.J., Mariman E.C. Regulation and expression of the murine PMP22 gene. Mamm. Genome. 10:1999;419-422.
74. Voyvodic J.T. Target size regulates calibre and myelination of sympathetic axons. Nature. 342:1989;430-433.
75. Warner L.E., Mancias P., Butler I.J., McDonald C.M., Keppen L., Koob K.G., Lupski J.R. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18:1998;382-384.
76. Wegner M. Transcriptional control in myelinating glia flavors and spices . Glia. 31:2000;1-14.
77. Wegner M. Transcriptional control in myelinating glia the basic recipe . Glia. 29:2000;118-123.
78. Welcher A.A., Suter U., De Leon M., Snipes G.J., Shooter E.M. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc. Natl. Acad. Sci. USA. 88:1991;7195-7199.
79. Wu R., Jurek M., Sundarababu S., Weinstein D.E. The POU gene Brn-5 is induced by neuregulin and is restricted to myelinating Schwann cells. Mol. Cell Neurosci. 17:2001;683-695.
80. Zoidl G., Blass-Kampmann S., D'Urso D., Schmalenbach C., Muller H.W. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells modulation of cell growth . EMBO J. 14:1995;1122-1128.
81. Zorick T.S., Lemke G. Schwann cell differentiation. Curr. Opin. Cell Biol. 8:1996;870-876.
82. Zorick T.S., Syroid D.E., Brown A., Gridley T., Lemke G. Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development. 126:1999;1397-1406.